Close Menu
Home » Clostridium difficile

Clostridium difficile

Nov 27, 2013

Researchers Characterize Microbiomes of Fecal Microbiota Transplant Patients Over Time

NEW YORK (GenomeWeb Daily News) – The microbiomes of recipients of fecal microbiota transplants undergo changes immediately following the procedure, and they continue to change, albeit at a much slower pace, for at least 16 weeks after treatment, researchers from the University of Maryland School

Nov 21, 2013

Researchers Share Early Clinical Data on Performance of Quidel MDx Assays

Premium

Researchers last week provided a glimpse of the clinical performance of a trio of extraction-free molecular assays currently being developed by clinical diagnostics firm Quidel.

Nov 21, 2013

Lucigen Details Polymerase Tailored for LAMP Assays; Potential in MDx Tests

Premium

Genomics tools provider Lucigen has developed an isothermal amplification polymerase ideally suited for use in loop-mediated isothermal amplification-based assays.

Nov 14, 2013

Dx Focus: FDA OKs IntelligentMDx C. Difficile Abbott m2000 Assay

Premium

IntelligentMDx said today that it has received US Food and Drug Administration clearance for its IMDx C.

Nov 12, 2013

FDA Clears IMDx C. Difficile Assay for Abbott m2000 System

NEW YORK (GenomeWeb News) – IntelligentMDx today said that the US Food and Drug Administration has cleared its C. difficile assay for the Abbott m2000 system.

Sep 26, 2013

Sequencing Study Suggests Range of C. difficile Infection Sources

NEW YORK (GenomeWeb News) – Exposure to symptomatic individuals within healthcare settings may account for just a fraction of Clostridium difficile infections, according to a study from the UK appearing online last night in the New England Journal of Medicine.

Jul 23, 2013

Microbial Genetics Analysis Company OpGen Receives CLIA Accreditation

NEW YORK (GenomeWeb News) – Microbioal genetic analysis firm OpGen today announced it has received Clinical Laboratory Improvement Amendments certification.

Jul 11, 2013

Study Shows High Sensitivity, Specificity for Abacus Diagnostica C. Diff Test

Premium

A new automated molecular diagnostic assay to detect toxigenic Clostridium difficile directly from stool samples was found to have comparable sensitivity and specificity to both the gold standard of culture-based testing and reference testing with a competing assay, Ceph

May 02, 2013

PrimeraDx Readying ICEPlex, C. Diff Assay for FDA; Developing Follow-on Infectious Disease Panels

Premium

PrimeraDx, a Mansfield, Mass.-based molecular diagnostics firm, is on track to submit its highly multiplexed PCR-based testing system and associated assay for Clostridium difficile to the US Food and Drug Administration this quarter, CEO Matt McManus said recently.

Apr 09, 2013

FDA Clears BD's C. difficile Assay for BD Max System

NEW YORK (GenomeWeb News) – Becton Dickinson's BD Diagnostics segment today said that its BD Max Cdiff Assay has been cleared by the US Food and Drug Administration for marketing in the US.

Pages

The Scan

Harder to Breathe

Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.

Sequence From the Jomon Period

The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.

Shifting Sands of Gene Variant Interpretation

Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.

This Week in Science

In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.

What's Popular?

In Clostridium difficile

  1. Mobidiag Secures €25M Loan to Build Test Menu

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.